摘要
Objectives: Although Mesencephalic astrocyte-derived neurotrophic factor (MANF) shows protection in multiple cells, the role of circulating MANF in patients with acute ischemic stroke (AIS) and transient ischemic attack (TIA) remains unclear. Here, we aimed to explore the value of circulating MANF levels in cerebral ischemic events. Materials and methods: Using a rat cerebral ischemic model, MANF expres-sion in ischemic brains and serum was detected. 50 AIS patients, 56 TIA patients and 48 controls were enrolled, and MANF mRNA, inflammatory cytokines and MANF concentrations in serum and different blood cell types were detected. The National Institutes of Health Stroke Scale (NIHSS) score and Alberta Stroke Pro-gram Early CT Score (ASPECTS) were used to evaluate stroke severity. Cerebrovas-cular recurrence within 90 d was documented during TIA follow-up. Results: MANF expression increased at 2h, peaking at 24h and decreased to baseline at 7d in rat ischemic brains and serum. Serum MANF concentrations increased at 24h and 7d in AIS patients compared to controls and were correlated with NIHSS score, ASPECTS and inflammatory cytokines. MANF protein was present in blood cells, while MANF mRNA levels did not differ between AIS patients and controls. MANF levels revealed a good value to diagnose TIA with area under the curve (AUC) of 0.949 (95% CI: 0.9093-0.9892). MANF levels were lower in TIA patients with recurrence compared to non-recurrence patients. The AUC for MANF to pre-dict a re-event was 0.80 (95% CI: 0.6746-0.9282). Conclusions: Serum MANF levels correlate with neuroprotection, stroke severity, inflammation, and TIA recurrence.
-
单位5; 中山大学; 1; 哈尔滨医科大学